Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study

BACKGROUND: Desmopressin orally disintegrating tablet (ODT) was approved in March 2012 in Japan; the post-market safety reports, which warned about adequate initial dose of desmopressin ODT, were published in 2014. However, it is unclear how the warning affected physician and patient behavior. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Takuma, Murakami, Takaaki, Yasoda, Akihiro, Sone, Masakatsu, Harada, Norio, Ogura, Masahito, Inagaki, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935623/
https://www.ncbi.nlm.nih.gov/pubmed/33747323
http://dx.doi.org/10.14740/jocmr4399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935623/
https://www.ncbi.nlm.nih.gov/pubmed/33747323
http://dx.doi.org/10.14740/jocmr4399

Ejemplares similares